[Fund Index | Funds By Family | Fund Top Performers]

Mutual Fund Top Performers - Large Blend

As of 30-Sep-09

Select a symbol for a detailed quote and links to additional information.

Top Performers - 3 Month (out of 2089) Fund Name Symbol Return Direxion Mthly S&P 500 Bull 2X Inv DXSLX 39.87% Rydex S&P 500 2x Strategy H RYTNX 32.51% Rydex S&P 500 2x Strategy A RYTTX 32.49% Rydex S&P 500 2x Strategy C RYCTX 32.31% ProFunds UltraBull Inv ULPIX 31.36% PIMCO Fundamental IndexPLUS TR Inst PXTIX 31.13% ProFunds UltraBull Svc ULPSX 31.10% PIMCO Fundamental IndexPLUS TR P PIXPX 30.97% PIMCO Fundamental IndexPLUS TR Admin PXTAX 30.91% PIMCO Fundamental IndexPLUS TR D PIXDX 30.90%
Top Performers - 1 Year (out of 2005) Fund Name Symbol Return Vanguard Capital Value VCVLX 29.62% Oakmark Select II OARLX 13.34% MassMutual Select Focused Value S MFVSX 13.33% Oakmark Select I OAKLX 13.30% MassMutual Select Focused Value Y MMFYX 13.25% MassMutual Select Focused Value L MMFVX 13.04% MassMutual Select Focused Value A MFVAX 12.81% MassMutual Select Focused Value N MFVNX 12.52% PIMCO Fundamental IndexPLUS TR Inst PXTIX 12.16% PIMCO Fundamental IndexPLUS TR P PIXPX 12.13%		Top Performers - 3 Year (out of 1704) Fund Name Symbol Ann. Ret. Stadion Managed Portfolio A ETFFX 4.68% Fairholme FAIRX 3.12% Parnassus Equity Income - Inst PRILX 2.67% BBH Core Select N BBTEX 2.59% Parnassus Equity Income - Inv PRBLX 2.44% First Eagle US Value I FEVIX 2.15% First Eagle US Value A FEVAX 1.91% RS Large Cap Alpha Y RCEYX 1.41% RS Large Cap Alpha A GPAFX 1.24% JPMorgan US Large Cap Core Plus R5 JCPRX 1.17%
Top Performers - 5 Year (out of 1352) Fund Name Symbol Ann. Ret. Fairholme FAIRX 8.54% Eaton Vance Dividend Builder I EIUTX 7.87% Eaton Vance Dividend Builder A EVTMX 7.63% Janus Contrarian J JSVAX 7.11% Janus Contrarian I JCONX 7.11% Janus Contrarian S JCNIX 7.03% Janus Contrarian A JCNAX 7.03% Eagle Growth & Income A HRCVX 7.01% Eaton Vance Dividend Builder B EMTMX 6.83% Eaton Vance Dividend Builder C ECTMX 6.83%

Get Morningstar's portfolio tools, data, and editorial insights, plus Analyst Reports on 1,450 stocks and 2,000 funds. Start your free 14-day trial today.